This is a research study to evaluate the usability of the Cogito digital therapeutics development platform.
The Cogito platform is designed to allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with no programming skills necessary. It will provide the components for building a digital therapeutic for any health condition and population.
And in this initial study, the research team plans to examine the usability of Cogito in building a digital therapeutic for substance use disorders (SUDs).
At least 18 years
PhD and/or MD-level (or equivalent) scientists at academic institutions or digital health companies at the level of Post-doctoral Fellow or higher.
Training or trained in substance use disorder (SUDs) research.
Must state a specific interest in digital therapeutics for SUDs.
Those who do not meet inclusion criteria.
Square2 Systems, Inc.
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator